Antibiotic Nephrotoxicity in Adult Patients With Cystic Fibrosis
Prospective Randomised Trial of 'Area Under the Curve' (AUC) Dosing Strategy for Intravenous Tobramycin Versus Standard Trough Dosing for Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis (CF)
Sponsor: The Leeds Teaching Hospitals NHS Trust
This NA trial investigates Cystic Fibrosis and is currently ongoing. The Leeds Teaching Hospitals NHS Trust leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Aug 2017 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Leeds Teaching Hospitals NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .